Cancer Treatment Today

Aplastic anemia in younger patients is generally an  immune disorders, in which the immune system attack newly forming red cells and kills them. For this reason, it is often treated with immunosuppression. The risks of supressing the immune system is greater in older people, and for this reason, the suppression of the immune system is more often used in younger patients. Older individuals and those who failed immune suppressing drugs, should go

Aplastic anemia in younger patients is generally immune mediated and is treated with immunosupression. When there is no sibling donor, cyclosporine(CSA) is recommended, usually in combination with other drugs but it can also be used alone(1). First-line treatment approaches include immunosuppressive treatment using the combination of antithymocyte globulin and cyclosporine A for patients without a sibling donor and HLA identical sibling transplant